Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System
· 2026-09-10 · 原文
DOI：10.64898/2026.09.08.26362577v1?rss=1
Background: Several Schedule I substances have demonstrated potential benefits for refractory psychiatric conditions and addiction. Some have been legalized at the state level, while others like kratom (mitragynine) are available over-the-counter in some states and illegal in others. A recent presidential executive order directs certain federal agencies to accelerate development and facilitate access to psychedelic drugs through increased funding and expedited FDA review. Studies investigating the therapeutic potential of these drugs are limited and focused disproportionately on efficacy over safety. Rigorous evaluation of cardiovascular safety, including potential arrhythmia liability, is essential. Methods: We analyzed reports from the FDA Adverse Event Reporting System from 2000-2024. i
讲义
讲义·推断 依据「原文」自动生成的结构化摘要（推断），非原文表述；以原文为准。
1. 人话版
Background: Several Schedule I substances have demonstrated potential benefits for refractory psychiatric conditions and addiction.
Some have been legalized at the state level, while others like kratom (mitragynine) are available over-the-counter in some states and illegal in others.
2. 领域脉络
A recent presidential executive order directs certain federal agencies to accelerate development and facilitate access to psychedelic drugs through increased funding and expedited FDA review.
3. 机制拆解
Rigorous evaluation of cardiovascular safety, including potential arrhythmia liability, is essential.
4. 证据与数字
Methods: We analyzed reports from the FDA Adverse Event Reporting System from 2000-2024.
5. 反例与边界
Studies investigating the therapeutic potential of these drugs are limited and focused disproportionately on efficacy over safety.
6. 跨领域连接与意外收获
思考本文机制能否迁移到你正在跟进的问题。
7. 可复用方法
把本文机制与你手头项目对照，找一个两周内能验证的最小实验。
8. 术语表
精读时把不熟的术语记入此处，作为下次回忆的锚点。